NCT03324945View on ClinicalTrials.gov

Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

October 12, 2018

Study Completion Date

April 1, 2019

Conditions
Chemotherapy-induced Cognitive Impairment
Interventions
BEHAVIORAL

Neurocognitive assessments

Baseline and post-chemotherapy neurocognitive testing. A sequentially-assigned subset of participants also receive baseline and post-chemotherapy neuroimaging (FMRI)

Trial Locations (1)

40536

University of Kentucky Markey Cancer Center, Lexington

All Listed Sponsors
collaborator

Office of US Army Medical Research and Material Command

UNKNOWN

lead

Rachel Miller

OTHER

NCT03324945 - Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter